- Remove All
 Your shopping cart is currently empty Your shopping cart is currently empty
Okadaic acid is a potent polyether marine toxin that primarily accumulates in the digestive glands of marine mollusks. It is a highly effective and selective inhibitor of protein phosphatases (PPs). By inhibiting these phosphatases, okadaic acid increases the phosphorylation levels of various proteins, acts as a tumor promoter, and induces tau protein phosphorylation. It can be used to establish models of Alzheimer’s disease and skin cancer.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 25 μg (124.2 μM * 250 μL in Ethanol)" | $200 | In Stock | |
| 50 μg (124.2 μM * 500 μL in Ethanol) | $300 | 35 days | |
| 100 μg (124.2 μM * 1 mL in Ethanol) | $460 | In Stock | 
| Description | Okadaic acid is a potent polyether marine toxin that primarily accumulates in the digestive glands of marine mollusks. It is a highly effective and selective inhibitor of protein phosphatases (PPs). By inhibiting these phosphatases, okadaic acid increases the phosphorylation levels of various proteins, acts as a tumor promoter, and induces tau protein phosphorylation. It can be used to establish models of Alzheimer’s disease and skin cancer. | 
| Targets&IC50 |  PP7:>1000 nM, PP5:3.5 nM, PP2A:0.1-0.3 nM, PP3:4 nM, PP3:3.7-4 nM, PP1:10-15 nM, PP4:0.1 nM, PP2:0.5 nM, PP1:15-50 nM, PP2B:~4000 nM | 
| In vitro | Okadaic acid, at concentrations ranging from 0 to 100 nM and after treatment periods of 24 or 48 hours, is capable of inhibiting the proliferation of AGS, MNK-45, and Caco 2 cells[3]. | 
| In vivo | Okadaic Acid (100 μg; icv; single dose) can be used in male Wistar rats (250-300 g) to establish an Alzheimer's disease model[6]. | 
| Disease Modeling Protocol | Establishment of Alzheimer's disease model 
 *Precautions: The above data are from literature and for reference only. It is recommended to determine the optimal experimental conditions based on preliminary experiments. | 
| Molecular Weight | 805 | 
| Formula | C44H68O13 | 
| Cas No. | 78111-17-8 | 
| Smiles | O[C@H]1[C@@]2(O[C@]([C@@H](/C=C/[C@@H]3O[C@]4(CC3)O[C@@]5([C@@](CC4)(O[C@]([C@H](C[C@H](C)[C@]6(O[C@]7(CC[C@H]6C)CCCCO7)[H])O)(C(=C)[C@H]5O)[H])[H])[H])C)(CC(C)=C2)[H])O[C@H](C[C@@](C(O)=O)(C)O)CC1 | 
| Relative Density. | 1.0795 g/cm3 (Estimated) | 
| Color | Transparent | 
| Appearance | Liquid | 
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
 For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .  A total of 10 animals were administered, and the formula you used is 5%
 A total of 10 animals were administered, and the formula you used is 5%  DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first. main solution, add 300 μLPEG300
 main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O
 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
 mix well and clarify
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.